Fellowship · Houston, TX
Sponsored by University of Texas M D Anderson Cancer Center
Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 80 citations · Valencia Thomas
Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy.
Nature · 2025 · 72 citations · Michael Migden
Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 103 citations · Valencia Thomas
Sunscreens and Photoaging: A Review of Current Literature.
American journal of clinical dermatology · 2021 · 168 citations · Linna Gali
Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease.
JAMA oncology · 2022 · 123 citations · Valencia Thomas
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.
The Lancet. Oncology · 2021 · 239 citations · Michael Migden
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6.
Journal of the American Academy of Dermatology · 2025 · 53 citations · Michael Migden
NCCN Guidelines® Insights: Merkel Cell Carcinoma, Version 1.2024.
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 55 citations · Valencia Thomas